# Actuate Therapeutics, Inc.: Form 8-K, filed May 23, 2025

- Company: [Actuate Therapeutics, Inc.](/companies/actu.md) (CIK 1652935)
- Form: 8-K
- Filed: 2025-05-23
- Accepted by EDGAR: May 23, 2025, 16:10 ET
- Period: 2025-05-22
- Accession: 0001683168-25-003995
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1652935/000168316825003995/actuate_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1652935/000168316825003995/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1652935/000168316825003995/actuate_8k.htm

Filed May 23, 2025.
Source: SEC EDGAR, the filing index for accession 0001683168-25-003995. Last ingested by Listed: Nov 2, 2026, 18:06 ET. No prices; not investment advice.